Atara Biotherapeutics (ATRA) Other Gross PP&E Adjustments (2022 - 2025)
Atara Biotherapeutics' Other Gross PP&E Adjustments history spans 4 years, with the latest figure at -$6.9 million for Q4 2025.
- For Q4 2025, Other Gross PP&E Adjustments rose 74.52% year-over-year to -$6.9 million; the TTM value through Dec 2025 reached -$6.9 million, up 74.52%, while the annual FY2025 figure was -$6.9 million, 74.52% up from the prior year.
- Other Gross PP&E Adjustments reached -$6.9 million in Q4 2025 per ATRA's latest filing, up from -$10.2 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $427000.0 in Q1 2022 to a low of -$68.5 million in Q4 2022.
- Average Other Gross PP&E Adjustments over 4 years is -$33.9 million, with a median of -$35.9 million recorded in 2023.
- Peak YoY movement for Other Gross PP&E Adjustments: crashed 10879.86% in 2023, then surged 74.52% in 2025.
- A 4-year view of Other Gross PP&E Adjustments shows it stood at -$68.5 million in 2022, then grew by 28.11% to -$49.2 million in 2023, then surged by 45.18% to -$27.0 million in 2024, then soared by 74.52% to -$6.9 million in 2025.
- Per Business Quant, the three most recent readings for ATRA's Other Gross PP&E Adjustments are -$6.9 million (Q4 2025), -$10.2 million (Q3 2025), and -$10.5 million (Q2 2025).